
Keywords: AT; antithrombin; AZ; AstraZeneca; CAT; calibrated automated thrombogram; ETP; endogenous thrombin potential; LT; lag time; HTS; high-throughput screening; PPP; platelet poor plasma; PRP; platelet rich plasma; RU; resonance units; SPR; surface plasmon res